Surgery Partners Stock Net Asset
| SGRY Stock | USD 23.39 0.38 1.65% |
Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.
Surgery | Net Asset |
Surgery Partners Company Net Asset Analysis
Surgery Partners' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Surgery Partners Net Asset | 6.88 B |
Most of Surgery Partners' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Surgery Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Net Asset. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Surgery Total Assets
Total Assets |
|
Based on the recorded statements, Surgery Partners has a Net Asset of 6.88 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Surgery Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.Surgery Partners is currently under evaluation in net asset category among its peers.
Surgery Partners ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Surgery Partners' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Surgery Partners' managers, analysts, and investors.Environmental | Governance | Social |
Surgery Partners Institutional Holders
Institutional Holdings refers to the ownership stake in Surgery Partners that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Surgery Partners' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Surgery Partners' value.| Shares | Goldman Sachs Group Inc | 2024-06-30 | 1.5 M | Victory Capital Management Inc. | 2024-09-30 | 1.3 M | Amvescap Plc. | 2024-06-30 | 1 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 903.9 K | Norges Bank | 2024-06-30 | 842.9 K | Avidity Partners Management Lp | 2024-09-30 | 827 K | Charles Schwab Investment Management Inc | 2024-09-30 | 772.7 K | Northern Trust Corp | 2024-09-30 | 746.1 K | Thorntree Capital Partners Lp | 2024-09-30 | 737 K | Bain Capital Investors Llc | 2024-09-30 | 49.9 M | Fmr Inc | 2024-09-30 | 18.3 M |
Surgery Fundamentals
| Return On Equity | 0.0308 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 6.22 B | ||||
| Shares Outstanding | 127.11 M | ||||
| Shares Owned By Insiders | 1.12 % | ||||
| Shares Owned By Institutions | 98.88 % | ||||
| Number Of Shares Shorted | 10.16 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.54 X | ||||
| Price To Sales | 0.98 X | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 574.9 M | ||||
| EBITDA | 446.1 M | ||||
| Net Income | (11.9 M) | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.06 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 15.00 X | ||||
| Cash Flow From Operations | 293.8 M | ||||
| Short Ratio | 17.29 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 36.29 | ||||
| Number Of Employees | 10.5 K | ||||
| Beta | 2.77 | ||||
| Market Capitalization | 2.92 B | ||||
| Total Asset | 6.88 B | ||||
| Retained Earnings | (569.2 M) | ||||
| Working Capital | 372 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
| Net Asset | 6.88 B |
About Surgery Partners Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.